2/4/2022, 7:36 AM (Source: TeleTrader)
more TeleTrader news


Chart for: Sanofi SA

Sanofi Q4 revenue grow 6.5% to €9.99 billion

Sanofi S.A. said on Friday that its revenue soared 6.5% in the fourth quarter of 2021 to reach €9.99 billion, mainly due to Specialty Care, driven by Dupixent. Sanofi's net income rose 6% to €1.13 billion, with earnings per share of €0.90.

Full-year 2021 net sales were €37.8 billion, 4.8% higher compared to the year before. Net income declined by 49.4% to €6.2 billion, and diluted earnings per share fell 49.3% to stand at €4.97 in 2021.

"Sanofi has closed 2021 with a strong performance in the fourth quarter driven by high double-digit sales growth of Dupixent®, which continues to set impressive record sales quarter after quarter. This quarter marks the first time Specialty Care has led our GBUs by sales, highlighting a significant milestone in our transformation," CEO Paul Hudson noted.

Baha Breaking News (BBN) / JG